Clemson University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Clemson University sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials 3 currently recruiting 10 completed top decile by trial count

Clemson University: 13 sponsored US clinical trials, 3 recruiting.

Clemson University sponsors 13 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 10 completed. The most-studied condition in this pipeline is Violence, Gender-Based, with 1 trials.

Top-decile sponsor footprint

Clemson University ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

What is open in the Clemson University pipeline

3 recruiting of 13 indexed (23% open); 10 completed (77%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Violence, Gender-Based (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Clemson University: open-pipeline peers nationwide

Peers matched on 13 registered trials and 23% open enrollment, not the therapeutic-area sidebar.

Clemson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1015202530 0%5%10%15%20%25% Total trials Recruiting share Clemson UniversityAdaptimmuneAgennixAkili Interactive LabsAlumisLiberating TechnologiesRahul AggarwalSequenomSumitomo Pharma Switzerland
Clemson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Clemson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 trials (± recruiting share)

Sponsors near 23% open enrollment (± trial volume)

What to do with this Clemson University page

13 registered trials is a research-attention snapshot, not an endorsement of Clemson University or any single study.

  • 3 of Clemson University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Violence, Gender-Based is the condition Clemson University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Violence, Gender-Based trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Clemson University pipeline card: 13 registered trials from official public datasets.Report a data error.